Search research articles
Contact Us
Filters
Showing results (11-20 of 229) with videos related to
Page
of 23
Sort By:
Current Opinion in Pharmacology
|
July 13, 2021
Alpha1-antitrypsin deficiency: New therapies on the horizon
Katharina Remih, Samira Amzou, Pavel Strnad
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2019
DEFI-ALFA: The French key to the alpha1 mystery?
Malin Fromme, Martin Oliverius, Pavel Strnad
Deutsche Medizinische Wochenschrift (1946)
|
June 1, 2021
[Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease]
Barbara Burbaum, Malin Fromme, Pavel Strnad
Respiratory Research
|
April 17, 2026
Comment: Increased exacerbations and hospitalizations among Pi*MZ compared to Pi*MM individuals?
Malin Fromme, Katharina Remih, Pavel Strnad
Molecular Therapy. Methods & Clinical Development
|
February 19, 2024
A gene silencing-based approach to tackle fatty liver disease
Pavel Strnad, Christina Schrader, Nicola Brunetti-Pierri
The Journal of Investigative Dermatology
|
January 25, 2003
Light-induced resistance of the keratin network to the filament-disrupting tyrosine phosphatase inhibitor orthovanadate
Pavel Strnad, Reinhard Windoffer, Rudolf E Leube
Gastroenterology
|
January 8, 2021
Reply
Carolin V Schneider, Karim Hamesch, Pavel Strnad
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 27, 2024
SNRK tames mTOR against metabolic dysfunction-associated steatotic liver disease
Nicola Brunetti-Pierri, Lisa Bewersdorf, Pavel Strnad
Best Practice & Research. Clinical Gastroenterology
|
June 19, 2017
Reversal of liver fibrosis: From fiction to reality
Miguel Eugenio Zoubek, Christian Trautwein, Pavel Strnad
Journal of Hepatology
|
November 12, 2022
Prediction of liver-related mortality in a community setting
Carolin V Schneider, Stefan Gross, Pavel Strnad
Page
of 23
Search research articles
Search
Showing results (11-20 of 229) with videos related to
Sort By:
Page
of 23
Current Opinion in Pharmacology
|
July 13, 2021
Alpha1-antitrypsin deficiency: New therapies on the horizon
Katharina Remih, Samira Amzou, Pavel Strnad
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 26, 2019
DEFI-ALFA: The French key to the alpha1 mystery?
Malin Fromme, Martin Oliverius, Pavel Strnad
Deutsche Medizinische Wochenschrift (1946)
|
June 1, 2021
[Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease]
Barbara Burbaum, Malin Fromme, Pavel Strnad
Respiratory Research
|
April 17, 2026
Comment: Increased exacerbations and hospitalizations among Pi*MZ compared to Pi*MM individuals?
Malin Fromme, Katharina Remih, Pavel Strnad
Molecular Therapy. Methods & Clinical Development
|
February 19, 2024
A gene silencing-based approach to tackle fatty liver disease
Pavel Strnad, Christina Schrader, Nicola Brunetti-Pierri
The Journal of Investigative Dermatology
|
January 25, 2003
Light-induced resistance of the keratin network to the filament-disrupting tyrosine phosphatase inhibitor orthovanadate
Pavel Strnad, Reinhard Windoffer, Rudolf E Leube
Gastroenterology
|
January 8, 2021
Reply
Carolin V Schneider, Karim Hamesch, Pavel Strnad
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 27, 2024
SNRK tames mTOR against metabolic dysfunction-associated steatotic liver disease
Nicola Brunetti-Pierri, Lisa Bewersdorf, Pavel Strnad
Best Practice & Research. Clinical Gastroenterology
|
June 19, 2017
Reversal of liver fibrosis: From fiction to reality
Miguel Eugenio Zoubek, Christian Trautwein, Pavel Strnad
Journal of Hepatology
|
November 12, 2022
Prediction of liver-related mortality in a community setting
Carolin V Schneider, Stefan Gross, Pavel Strnad
Page
of 23